Top3β is an RNA topoisomerase that works with fragile X syndrome protein to promote synapse formation

Nature Neuroscience

Volumn 16, Issue 9, 2013, Pages 1238-1247

  Xu, Dongyi ^a,b   Shen, Weiping ^a   Guo, Rong ^a   Xue, Yutong ^a   Peng, Wei ^a   Sima, Jian ^c   Yang, Jay ^d   Sharov, Alexei ^c   Srikantan, Subramanya ^c   Yang, Jiandong ^a   Fox, David ^a   Qian, Yong ^c   Martindale, Jennifer L ^c   Piao, Yulan ^c   Machamer, James ^e   Joshi, Samit R ^f   Mohanty, Subhasis ^f   Shaw, Albert C ^f   Lloyd, Thomas E ^e   Brown, Grant W ^d   Ko, Minoru S H ^c   Gorospe, Myriam ^c   Zou, Sige ^c   Wang, Weidong ^a   more..

^a NATIONAL INSTITUTE ON AGING   (United States)

^b PEKING UNIVERSITY   (China)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d UNIVERSITY OF TORONTO   (Canada)

^e JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA TOPOISOMERASE; FOCAL ADHESION KINASE 1; FRAGILE X MENTAL RETARDATION PROTEIN; MESSENGER RNA; POSTSYNAPTIC DENSITY PROTEIN 95; PROTEIN FMRP; RIBONUCLEASE A; RNA; RNA TOPOISOMERASE; SYNAPTOPHYSIN; TOPOISOMERASE 3BETA; TUDOR DOMAIN CONTAINING PROTEIN 3; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTISM; CELL STRAIN HEK293; CONTROLLED STUDY; CROSS LINKING; DELETION MUTANT; DROSOPHILA; EMBRYO; FEMALE; FRACTIONATION; FRAGILE X SYNDROME; GEL FILTRATION; GENE EXPRESSION; GENE INTERACTION; GENE TARGETING; HELA CELL; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; KNOCKOUT MOUSE; MALE; MASS SPECTROMETRY; MISSENSE MUTATION; MOUSE; NERVE CELL DIFFERENTIATION; NEUROMUSCULAR SYNAPSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; POLYSOME; PRIORITY JOURNAL; RNA BINDING; RNA METABOLISM; RNA TRANSLATION; SCHIZOPHRENIA; SYNAPSE; SYNAPTOGENESIS; WILD TYPE;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; CELLS, CULTURED; CHICKENS; DNA TOPOISOMERASES, TYPE I; DROSOPHILA; DROSOPHILA PROTEINS; EMBRYO, MAMMALIAN; EYE; FRAGILE X MENTAL RETARDATION PROTEIN; GENE EXPRESSION REGULATION; HUMANS; MICE; MICE, INBRED C57BL; NERVE TISSUE PROTEINS; NEUROGENESIS; NEUROMUSCULAR JUNCTION; NEURONS; RNA-BINDING PROTEINS; TRANSFECTION;

EID: 84883429403     PISSN: 10976256     EISSN: 15461726     Source Type: Journal    
DOI: 10.1038/nn.3479     Document Type: Article

References (63)

1. Wang, J.C. Cellular roles of DNA topoisomerases: a molecular perspective. Nat. Rev. Mol. Cell Biol. 3, 430-440 (2002).
2. Wang, H., Di Gate, R.J. & Seeman, N.C. An RNA topoisomerase. Proc. Natl. Acad. Sci. USA 93, 9477-9482 (1996).
3. Li, W. & Wang, J.C. Mammalian DNA topoisomerase IIIα is essential in early embryogenesis. Proc. Natl. Acad. Sci. USA 95, 1010-1013 (1998).
4. Plank, J.L., Chu, S.H., Pohlhaus, J.R., Wilson-Sali, T. & Hsieh, T.S. Drosophila melanogaster topoisomerase IIIα preferentially relaxes a positively or negatively supercoiled bubble substrate and is essential during development. J. Biol. Chem. 280, 3564-3573 (2005).
5. Wu, J., Hou, J.H. & Hsieh, T.S. A new Drosophila gene wh (wuho) with WD40 repeats is essential for spermatogenesis and has maximal expression in hub cells. Dev. Biol. 296, 219-230 (2006).
6. Kwan, K.Y. et al. Development of autoimmunity in mice lacking DNA topoisomerase 3β. Proc. Natl. Acad. Sci. USA 104, 9242-9247 (2007).
7. Mohanty, S. et al. Defective p53 engagement after the induction of DNA damage in cells deficient in topoisomerase 3β. Proc. Natl. Acad. Sci. USA 105, 5063-5068 (2008).
8. Seki, M. et al. Bloom helicase and DNA topoisomerase IIIα are involved in the dissolution of sister chromatids. Mol. Cell. Biol. 26, 6299-6307 (2006).
9. Xu, D. et al. RMI, a new OB-fold complex essential for Bloom syndrome protein to maintain genome stability. Genes Dev. 22, 2843-2855 (2008).
10. Schizophrenia Psychiatric Genome-Wide Association Study (GWAS) Consortium. Genome-wide association study identifies five new schizophrenia loci. Nat. Genet. 43, 969-976 (2011).
11. Verkerk, A.J. et al. Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell 65, 905-914 (1991).
12. Bhakar, A.L., Dolen, G. & Bear, M.F. The pathophysiology of fragile X (and what it teaches us about synapses). Annu. Rev. Neurosci. 35, 417-443 (2012).
13. Darnell, J.C. et al. FMRP stalls ribosomal translocation on mRNAs linked to synaptic function and autism. Cell 146, 247-261 (2011).
14. Linder, B. et al. Tdrd3 is a novel stress granule-associated protein interacting with the fragile-X syndrome protein FMRP. Hum. Mol. Genet. 17, 3236-3246 (2008).
15. Côteó, J. & Richard, S. Tudor domains bind symmetrical dimethylated arginines. J. Biol. Chem. 280, 28476-28483 (2005).
16. Stetler, A. et al. Identification and characterization of the methyl arginines in the fragile X mental retardation protein Fmrp. Hum. Mol. Genet. 15, 87-96 (2006).
17. Yin, J. et al. BLAP75, an essential component of Bloom's syndrome protein complexes that maintain genome integrity. EMBO J. 24, 1465-1476 (2005).
18. Wang, F. et al. Crystal structures of RMI1 and RMI2, two OB-fold regulatory subunits of the BLM complex. Structure 18, 1159-1170 (2010).
19. Goulet, I., Boisvenue, S., Mokas, S., Mazroui, R. & Cote, J. TDRD3, a novel Tudor domain-containing protein, localizes to cytoplasmic stress granules. Hum. Mol. Genet. 17, 3055-3074 (2008).
20. Buchan, J.R. & Parker, R. Eukaryotic stress granules: the ins and outs of translation. Mol. Cell 36, 932-941 (2009).
21. Khandjian, E.W., Corbin, F., Woerly, S. & Rousseau, F. The fragile X mental retardation protein is associated with ribosomes. Nat. Genet. 12, 91-93 (1996).
22. Tamanini, F. et al. FMRP is associated to the ribosomes via RNA. Hum. Mol. Genet. 5, 809-813 (1996).
23. Feng, Y. et al. FMRP associates with polyribosomes as an mRNP, and the I304N mutation of severe fragile X syndrome abolishes this association. Mol. Cell 1, 109-118 (1997).
24. Yang, J., Bachrati, C.Z., Ou, J., Hickson, I.D. & Brown, G.W. Human topoisomerase IIIα is a single-stranded DNA decatenase that is stimulated by BLM and RMI1. J. Biol. Chem. 285, 21426-21436 (2010).
25. Wilson, T.M., Chen, A.D. & Hsieh, T. Cloning and characterization of Drosophila topoisomerase IIIβ. Relaxation of hypernegatively supercoiled DNA. J. Biol. Chem. 275, 1533-1540 (2000).
26. Siomi, H., Choi, M., Siomi, M.C., Nussbaum, R.L. & Dreyfuss, G. Essential role for KH domains in RNA binding: impaired RNA binding by a mutation in the KH domain of FMR1 that causes fragile X syndrome. Cell 77, 33-39 (1994).
27. Licatalosi, D.D. et al. HITS-CLIP yields genome-wide insights into brain alternative RNA processing. Nature 456, 464-469 (2008).
28. Wan, L., Dockendorff, T.C., Jongens, T.A. & Dreyfuss, G. Characterization of dFMR1, a Drosophila melanogaster homolog of the fragile X mental retardation protein. Mol. Cell. Biol. 20, 8536-8547 (2000).
29. Zarnescu, D.C. et al. Fragile X protein functions with lgl and the par complex in flies and mice. Dev. Cell 8, 43-52 (2005).
30. Cziko, A.M. et al. Genetic modifiers of dFMR1 encode RNA granule components in Drosophila. Genetics 182, 1051-1060 (2009).
31. Zhang, Y.Q. et al. Drosophila fragile X-related gene regulates the MAP1B homolog Futsch to control synaptic structure and function. Cell 107, 591-603 (2001).
32. Bhogal, B. et al. Modulation of dADAR-dependent RNA editing by the Drosophila fragile X mental retardation protein. Nat. Neurosci. 14, 1517-1524 (2011).
33. Stoll, G. et al. Deletion of Top3b, a component of FMRP-containing mRNPs, contributes to neurodevelopmental disorders. Nat. Neurosci. advance online publication, http://dx.doi.org/10.1038/nn.3484 (4 August 2013).
34. Xu, B. et al. De novo gene mutations highlight patterns of genetic and neural complexity in schizophrenia. Nat. Genet. 44, 1365-1369 (2012).
35. Iossifov, I. et al. De novo gene disruptions in children on the autistic spectrum. Neuron 74, 285-299 (2012).
36. Gilman, S.R. et al. Diverse types of genetic variation converge on functional gene networks involved in schizophrenia. Nat. Neurosci. 15, 1723-1728 (2012).
37. Sullivan, P.F. et al. Family history of schizophrenia and bipolar disorder as risk factors for autism. Arch. Gen. Psychiatry 69, 1099-1103 (2012).
38. Walsh, T. et al. Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia. Science 320, 539-543 (2008).
39. Rico, B. et al. Control of axonal branching and synapse formation by focal adhesion kinase. Nat. Neurosci. 7, 1059-1069 (2004).
40. Liu, G. et al. Netrin requires focal adhesion kinase and Src family kinases for axon outgrowth and attraction. Nat. Neurosci. 7, 1222-1232 (2004).
41. Tsai, P.I. et al. Fak56 functions downstream of integrin αPS3β? and suppresses MAPK activation in neuromuscular junction growth. Neural Dev. 3, 26 (2008).
42. Pfeiffer, B.E. & Huber, K.M. Fragile X mental retardation protein induces synapse loss through acute postsynaptic translational regulation. J. Neurosci. 27, 3120-3130 (2007).
43. Wells, S.E., Hillner, P.E., Vale, R.D. & Sachs, A.B. Circularization of mRNA by eukaryotic translation initiation factors. Mol. Cell 2, 135-140 (1998).
44. Chen, J. & Kastan, M.B. 5′-3′-UTR interactions regulate p53 mRNA translation and provide a target for modulating p53 induction after DNA damage. Genes Dev. 24, 2146-2156 (2010).
45. Svoboda, P. & Di Cara, A. Hairpin RNA: a secondary structure of primary importance. Cell. Mol. Life Sci. 63, 901-908 (2006).
46. Brierley, I., Gilbert, R.J. & Pennell, S. RNA pseudoknots and the regulation of protein synthesis. Biochem. Soc. Trans. 36, 684-689 (2008).
47. Memczak, S. et al. Circular RNAs are a large class of animal RNAs with regulatory potency. Nature 495, 333-338 (2013).
48. Hansen, T.B. et al. Natural RNA circles function as efficient microRNA sponges. Nature 495, 384-388 (2013).
49. Todd, P.K., Mack, K.J. & Malter, J.S. The fragile X mental retardation protein is required for type-I metabotropic glutamate receptor-dependent translation of PSD-95. Proc. Natl. Acad. Sci. USA 100, 14374-14378 (2003).
50. Kwan, K.Y. et al. Species-dependent posttranscriptional regulation of NOS1 by FMRP in the developing cerebral cortex. Cell 149, 899-911 (2012).
51. Ling, C. et al. FAAP100 is essential for activation of the Fanconi anemia-associated DNA damage response pathway. EMBO J. 26, 2104-2114 (2007).
52. Tamanini, F. et al. Differential expression of FMR1, FXR1 and FXR2 proteins in human brain and testis. Hum. Mol. Genet. 6, 1315-1322 (1997).
53. Fox, G.L., Rebay, I. & Hynes, R.O. Expression of DFak56, a Drosophila homolog of vertebrate focal adhesion kinase, supports a role in cell migration in vivo. Proc. Natl. Acad. Sci. USA 96, 14978-14983 (1999).
54. Xu, D. et al. Rif1 provides a new DNA-binding interface for the Bloom syndrome complex to maintain normal replication. EMBO J. 29, 3140-3155 (2010).
55. Islam, M.N., Fox, D. III, Guo, R., Enomoto, T. & Wang, W. RecQL5 promotes genome stabilization through two parallel mechanisms-interacting with RNA polymerase II and acting as a helicase. Mol. Cell. Biol. 30, 2460-2472 (2010).
56. Lee, E.K. et al. hnRNP C promotes APP translation by competing with FMRP for APP mRNA recruitment to P bodies. Nat. Struct. Mol. Biol. 17, 732-739 (2010).
57. Bentley, D.R. Whole-genome re-sequencing. Curr. Opin. Genet. Dev. 16, 545-552 (2006).
58. Ascano, M. Jr. et al. FMRP targets distinct mRNA sequence elements to regulate protein expression. Nature 492, 382-386 (2012).
59. Sun, J. et al. A multi-dimensional evidence-based candidate gene prioritization approach for complex diseases-schizophrenia as a case. Bioinformatics 25, 2595-6602 (2009).
60. Chandrasekaran, S. & Bonchev, D.G. A network view on schizophrenia related genes. New Biol. 2, 16-25 (2012).
61. Gaengel, K. & Mlodzik, M. Microscopic analysis of the adult Drosophila retina using semithin plastic sections. Methods Mol. Biol. 420, 277-287 (2008).
62. Kwan, K.Y. & Wang, J.C. Mice lacking DNA topoisomerase IIIβ develop to maturity but show a reduced mean lifespan. Proc. Natl. Acad. Sci. USA 98, 5717-5721 (2001).
63. Kim, Y.G. & Lee, Y.I. Differential expressions of synaptogenic markers between primary cultured cortical and hippocampal neurons. Exp. Neurobiol. 21, 61-67 (2012).